Descriptor English: | Kallmann Syndrome | ||||
Descriptor Spanish: |
Síndrome de Kallmann
| ||||
Descriptor Portuguese: | Síndrome de Kallmann | ||||
Descriptor French: | Syndrome de Kallmann | ||||
Entry term(s): |
Anosmic Hypogonadism Anosmic Hypogonadisms Anosmic Idiopathic Hypogonadotropic Hypogonadism Autosomal Dominant Form of Kallmann Syndrome Autosomal Recessive Form of Kallmann Syndrome Dysplasia Olfactogenitalis of De Morsier Hypogonadism, Anosmic Hypogonadisms, Anosmic Hypogonadotropic Hypogonadism and Anosmia Hypogonadotropic Hypogonadism, Anosmia, and Midline Cranial Anomalies (Cleft Lip, Cleft Palate and Imperfect Fusion) Hypogonadotropic Hypogonadism-Anosmia Syndrome Kallmann Syndrome 1 Kallmann Syndrome 2 Kallmann Syndrome 3 Kallmann Syndrome, Type 1, X-linked Kallmann Syndrome, Type 3, Recessive Kallmann's Syndrome Kallmanns Syndrome Syndrome, Kallmann Syndrome, Kallmann's |
||||
Tree number(s): |
C12.050.351.875.253.096.750 C12.200.706.316.096.750 C12.800.316.096.750 C16.131.939.316.096.750 C16.320.467 C19.391.119.096.750 C19.391.482.600 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D017436 | ||||
Scope note: | A genetically heterogeneous disorder caused by hypothalamic GNRH deficiency and OLFACTORY NERVE defects. It is characterized by congenital HYPOGONADOTROPIC HYPOGONADISM and ANOSMIA, possibly with additional midline defects. It can be transmitted as an X-linked (GENETIC DISEASES, X-LINKED), an autosomal dominant, or an autosomal recessive trait. |
||||
Allowable Qualifiers: |
BL blood CF cerebrospinal fluid CI chemically induced CL classification CO complications DG diagnostic imaging DH diet therapy DI diagnosis DT drug therapy EC economics EH ethnology EM embryology EN enzymology EP epidemiology ET etiology GE genetics HI history IM immunology ME metabolism MI microbiology MO mortality NU nursing PA pathology PC prevention & control PP physiopathology PS parasitology PX psychology RH rehabilitation RT radiotherapy SU surgery TH therapy UR urine VE veterinary VI virology |
||||
Previous Indexing: |
Hypogonadism (1966-1992) |
||||
Public MeSH Note: | 93 |
||||
History Note: | 93 |
||||
Related: |
Gonadotropin-Releasing Hormone
MeSH Receptor, Fibroblast Growth Factor, Type 1 MeSH | ||||
DeCS ID: | 30678 | ||||
Unique ID: | D017436 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 1993/01/01 | ||||
Date of Entry: | 1992/05/20 | ||||
Revision Date: | 2013/07/08 |
|
Kallmann Syndrome
- Preferred
Kallmann Syndrome 1
- Narrower
Kallmann Syndrome 3
- Narrower
Kallmann Syndrome 2
- Narrower
Concept UI |
M0026453 |
Scope note | A genetically heterogeneous disorder caused by hypothalamic GNRH deficiency and OLFACTORY NERVE defects. It is characterized by congenital HYPOGONADOTROPIC HYPOGONADISM and ANOSMIA, possibly with additional midline defects. It can be transmitted as an X-linked (GENETIC DISEASES, X-LINKED), an autosomal dominant, or an autosomal recessive trait. |
Preferred term | Kallmann Syndrome |
Entry term(s) |
Anosmic Hypogonadism Anosmic Hypogonadisms Anosmic Idiopathic Hypogonadotropic Hypogonadism Dysplasia Olfactogenitalis of De Morsier Hypogonadism, Anosmic Hypogonadisms, Anosmic Hypogonadotropic Hypogonadism and Anosmia Hypogonadotropic Hypogonadism-Anosmia Syndrome Kallmann's Syndrome Kallmanns Syndrome Syndrome, Kallmann Syndrome, Kallmann's |
Concept UI |
M0472223 |
Scope note | Type 1 is the X-linked form with mutations of gene Kal1 which encodes anosmin-1 protein that plays a key role in the migration of GNRH-containing neurons and olfactory nerves to the HYPOTHALAMUS. |
Preferred term | Kallmann Syndrome 1 |
Entry term(s) |
Kallmann Syndrome, Type 1, X-linked |
Concept UI |
M0530007 |
Preferred term | Kallmann Syndrome 3 |
Entry term(s) |
Autosomal Recessive Form of Kallmann Syndrome Hypogonadotropic Hypogonadism, Anosmia, and Midline Cranial Anomalies (Cleft Lip, Cleft Palate and Imperfect Fusion) Kallmann Syndrome, Type 3, Recessive |
Concept UI |
M0472224 |
Scope note | Type 2 is an autosomal dominant form with loss-of-function mutations of gene Kal2 which encodes fibroblast growth-factor receptor-1 (FGFR1 PROTEIN). |
Preferred term | Kallmann Syndrome 2 |
Entry term(s) |
Autosomal Dominant Form of Kallmann Syndrome |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey